AIM ImmunoTech Inc.
AIM · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $6 | $7 | $8 | $11 |
| - Cash | $2 | $0 | $1 | $2 |
| + Debt | $2 | $3 | $3 | $3 |
| Enterprise Value | $6 | $9 | $10 | $13 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 4% | 56.3% | -64.4% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -369.2% | 60% | 37.5% | 213.3% |
| EBITDA | -$3 | -$3 | -$3 | -$6 |
| % Margin | -11,853.8% | -10,360% | -21,618.8% | -12,824.4% |
| Net Income | -$3 | -$3 | -$4 | -$6 |
| % Margin | -12,630.8% | -11,176% | -23,156.3% | -13,260% |
| EPS Diluted | -1,568.71 | -3.68 | -0.05 | -0.1 |
| % Growth | -42,528% | -7,260% | 50% | – |
| Operating Cash Flow | -$5 | -$2 | -$2 | -$4 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$5 | -$2 | -$2 | -$4 |